Effectiveness and cost-effectiveness of pediatric rotavirus vaccination in British Columbia: A model-based evaluation

Medicine & Life Sciences

• British Columbia 100%
• Rotavirus 91%
• Gastroenteritis 87%
• Cost-Benefit Analysis 68%
• Vaccination 63%
• Pediatrics 50%
• RotaTeq 37%
• RIX4414 vaccine 37%
• Rotavirus Vaccines 31%
• Canada 30%
• Health Care Costs 30%
• Vaccines 25%
• Delivery of Health Care 20%
• Child 19%
• Immunization 18%
• Infections 16%
• Markov Chains 15%
• Costs and Cost Analysis 14%
• Child Mortality 13%
• Cost of Illness 13%
• Morbidity 13%
• Quality-Adjusted Life Years 12%
• Natural History 11%
• Income 9%
• Epidemiology 8%
• Economics 8%
• Outpatients 8%
• Hospitalization 8%
• Health 5%
• Population 4%

Agriculture & Biology

• pediatrics 99%
• Rotavirus 96%
• British Columbia 86%
• cost effectiveness 84%
• gastroenteritis 84%
• vaccination 71%
• health care costs 44%
• vaccines 42%
• health services 31%
• Canada 24%
• morbidity 20%
• immunization 19%
• quality-adjusted life year 17%
• infection 15%
• burden of disease 14%
• Markov chain 12%
• childhood 11%
• economic analysis 11%
• natural history 10%
• epidemiology 9%
• income 8%
• economics 6%
• methodology 2%

Social Sciences

• vaccination 88%
• Healthcare 60%
• costs 44%
• projection 36%
• evaluation 35%
• utilization 31%
• morbidity 26%
• Canada 26%
• life years 17%
• hospitalization 14%
• epidemiology 13%
• social attraction 13%
• economics 11%
• mortality 11%
• incident 10%
• illness 10%
• simulation 10%
• coverage 9%
• childhood 9%
• income 8%
• interpretation 7%
• history 7%
• health 5%